Aehr Test Systems, Inc.
AEHR
$8.78
-$0.10-1.13%
| Weiss Ratings | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C | |||
| Rating Factors | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.05 | |||
| Price History | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -7.38% | |||
| 30-Day Total Return | -22.58% | |||
| 60-Day Total Return | -23.85% | |||
| 90-Day Total Return | -37.64% | |||
| Year to Date Total Return | -46.95% | |||
| 1-Year Total Return | -39.45% | |||
| 2-Year Total Return | -72.25% | |||
| 3-Year Total Return | -3.09% | |||
| 5-Year Total Return | 619.67% | |||
| 52-Week High % Change | -59.05% | |||
| 52-Week Low % Change | 10.93% | |||
| Price | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $21.44 | |||
| 52-Week Low Price | $7.92 | |||
| 52-Week Low Price (Date) | Mar 11, 2025 | |||
| 52-Week High Price (Date) | Jul 17, 2024 | |||
| Valuation | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 260.87M | |||
| Enterprise Value | 235.08M | |||
| Price/Earnings (TTM) | 11.74 | |||
| Earnings Per Share (TTM) | 0.75 | |||
| Earnings Per Share Growth | 5.54% | |||
| Price/Earnings To Growth | 2.12 | |||
| Price/Sales (TTM) | 5.13 | |||
| Price/Book (Q) | 2.12 | |||
| Enterprise Value/Revenue (TTM) | 4.63 | |||
| Price | $8.78 | |||
| Enterprise Value/EBITDA (TTM) | 1,098.53 | |||
| Enterprise Value/EBIT | -273.67 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 29.66M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 510 623 9400 | |||
| Address | 400 Kato Terrace Fremont, CA 94539 | |||
| Website | www.aehr.com | |||
| Country | United States | |||
| Year Founded | 1977 | |||
| Profitability | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -1.69% | |||
| Profit Margin | 43.41% | |||
| Management Effectiveness | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -0.44% | |||
| Return on Equity | 20.94% | |||
| Income Statement | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 50.74M | |||
| Total Revenue (TTM) | 50.74M | |||
| Revenue Per Share | $1.71 | |||
| Gross Profit (TTM) | 24.08M | |||
| EBITDA (TTM) | 214.00K | |||
| EBIT (TTM) | -859.00K | |||
| Net Income (TTM) | 22.03M | |||
| Net Income Avl. to Common (TTM) | 22.03M | |||
| Total Revenue Growth (Q YOY) | -37.23% | |||
| Earnings Growth (Q YOY) | -116.88% | |||
| EPS Diluted (TTM) | 0.75 | |||
| EPS Diluted Growth (Q YOY) | -117.35% | |||
| Balance Sheet | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 32.22M | |||
| Cash Per Share (Q) | $1.09 | |||
| Total Current Assets (Q) | 88.52M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 123.18M | |||
| Current Ratio (Q) | 7.555 | |||
| Book Value Per Share (Q) | $4.15 | |||
| Total Assets (Q) | 142.28M | |||
| Total Current Liabilities (Q) | 11.72M | |||
| Total Debt (Q) | 6.43M | |||
| Total Liabilities (Q) | 19.10M | |||
| Total Common Equity (Q) | 123.18M | |||
| Cash Flow | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -11.44M | |||
| Cash from Financing (TTM) | 1.07M | |||
| Net Change in Cash (TTM) | -15.50M | |||
| Levered Free Cash Flow (TTM) | -7.61M | |||
| Cash from Operations (TTM) | -5.09M | |||
